Year: 2026
Type: article
Abstract: Extracorporeal membrane oxygenation (ECMO) is an established technology that provides life-saving mechanical support for critically ill children. In these children, fluid overload is commonly treated with furosemide; however, optimal dosing of furosemide is unknown in children supported with ECMO because ECMO may alter furosemide exposure. In this work, human blood-primed ex vivo experiments quantified red blood cell partitioning and extraction of furosemide by the ECMO circuit. Furosemide partitioned into red blood cells but was not extracted by ECMO circuits. These data then parameterized a pediatric physiologically based pharmacokinetic (PBPK) model of furosemide in children with and without ECMO. Next, plasma furosemide concentrations from 10 critically ill children supported by ECMO were used to evaluate PBPK model performance, with the optimized model achieving average fold error and absolute average fold error of 1.02 and 1.67, respectively. The optimized PBPK model also predicted that ECMO increases apparent volume of distribution by a median of > 30% in neonates and infants. Finally, population PBPK simulations with the optimized PBPK model provided initial bolus doses that most rapidly achieve steady-state plasma furosemide concentrations with and without ECMO. These calibrated initial bolus doses achieved steady-state plasma furosemide concentrations > 3 h faster than continuous infusions without an initial bolus dose, and this improvement was most pronounced in neonates and infants on ECMO. Overall, this work supports comparatively larger initial bolus doses for neonates and infants on ECMO, and provides calibrated initial bolus doses based on plasma exposure for critically ill children.
DOI: 10.1002/psp4.70370
Institution: University of Utah
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,140
Funders: American Foundation for Pharmaceutical Education, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: Physiologically-Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support, Investigation of Drug-Drug and Drug-Circuit Interactions in Children on Continuous Renal Replacement Therapy, The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC), Multidisciplinary Pulmonary and Critical Care Training Program, National Career Development Program for Researchers in Pediatric Clinical Pharmacology, Optimal Dosing of CNS Drugs for Children, Anakinra Dosing in Children with Sepsis Induced MODS: A Physiologically Based Pharmacokinetic-Pharmacodynamic Approach, Home vs. Clinic Collection of Human Milk in Evaluating the Pharmacokinetics of Four Medications
OpenAlex ID: W7235868754
